IreneHRichardMD

PubMed

• 1576 citations
  Unified huntington’s disease rating scale: Reliability and consistency
  Karl Kieburtz, John B. Penney, Peter Corno, Neal G. Ranen, Ira Shoulson
  Movement Disorders. 2001-02-27
• 403 citations
  AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial
  Peter A. LeWitt, Ali R. Rezai, Maureen A. Leehey, Steven G. Ojemann, Alice W. Flaherty
  The Lancet. Neurology. 2011-04-01
• 965 citations
  The Parkinson Progression Marker Initiative (PPMI)
  Kenneth Marek, Danna Jennings, Shirley Lasch, Andrew Siderowf, Caroline M. Tanner
  Progress in Neurobiology. 2011-12-01

Journal Articles

• Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease  
  Weintraub D, Simuni T, Caspell-Garcia C, Coffey C, Lasch S, Siderowf A, Aarsland D, Barone P, Burn D, Chahine LM, Eberling J, Espay AJ, Foster ED, Leverenz JB, Litvan ..., Mov Disord, 1/4/2015
• Feasibility of virtual research visits in Fox Trial Finder  
  Dorsey ER, Wagner JD, Bull MT, Rizzieri A, Grischkan J, Achey MA, Sherer T, Chowdury S, Meunier C, Cappelletti L, Rocker C, Richard IH, Schwarz H, Kang G, Ahmad SH, Bi..., Journal of Parkinson's disease, 1/1/2015
• Factor analysis of the Hamilton Depression Rating Scale in Parkinson's disease  
  Broen MP, Moonen AJ, Kuijf ML, Dujardin K, Marsh L, Richard IH, Starkstein SE, Martinez-Martin P, Leentjens AF, Parkinsonism Relat Disord, 1/1/2015
• Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease  
  A.J.H. Moonen, A. Wijers, A.F.G. Leentjens, C.W. Christine, S. Factor, J.L. Juncos, J.M. Lyness, L. Marsh, M. Panisset, R.F. Pfeiffer, D.A. Rottenberg, C. Serrano Ramo..., Parkinsonism & Related Disorders, 1/1/2014
• Managing depression in Parkinson's patients: risk factors and clinical pearls  
  Beimiller, Rachel and Richard IH, Neurodegen. Dis. Manage, 1/1/2014
• Anxiety Has Specific Syndromal Profiles in Parkinson Disease: A Data-Driven Approach  
  Starkstein SE, Dragovic M, Dujardin K, Marsh L, Martinez-Martin P, Pontone GM, Richard IH, Weintraub D, Leentjens AF, Am J Geriatr Psychiatry, 1/4/2013
• Modeling depression in Parkinson's disease: disease-specific and non-specific risk factors  
  Leentjens AFG, Moonen AJH, Dujardin K, Marsh L, Martinez-Martin P, Richard IH, Starkstein SE, and Kohler S, Neurology, 1/1/2013
• Rasch analysis of anxiety scales in Parkinson's disease  
  Forjaz MJ, Martinez-Martin P, Dujardin K, Marsh L, Richard IH, Starkstein SS, Leentjens AF, J Psychosomatic Res, 1/1/2013
• A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson's disease  
  Richard, IH, McDermott MP, Kurlan RM, Lyness JM, Como PG, Pearson MJ, Factor SA, Juncos JL, Serrano Ramos C, Brodsky MA, Manning C, Marsh LM, Fernandez Hubert H, Black..., Neurology, 1/1/2012
• Anxiety and motor fluctuations in Parkinson's disease: a cross-sectional observational study  
  Leentjens AFG, Dujardin K, Marsh L, Richard IH, Starkstein SE, Martinez-Martin P, Parkinsonism and Related Disorders, 1/1/2012
• Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome study  
  Siderowf A, Jennings D, Eberly S, Oakes D, Hawkins KA, Ascherio A, Stern MB, Marek K and PARS Investigators (I Richard, Site Investigator), Movement Disorders, 1/1/2012
• A Randomized Pilot Trial Of Estrogen Replacement Therapy In Post-Menopausal Women With Parkinson's Disease  
  The Parkinson Study Group POETRY Investigators (I Richard, Site Investigator), Parkinsonism and Related Disorders, 1/1/2011
• A randomized multicenter double-blind clinical trial of AAV2-GAD gene therapy for advanced Parkinson's disease  
  LeWitt PA, Rezai AR, Leehey MA, Ojemann SG, Flaherty AW, Eskandar EN, Kostyk SK, Thomas K, Sarkar A, Siddiqui MS, Tatter SB, Schwalb JM, Poston KL, Henderson JM, Kurla..., Lancet Neurology, 1/1/2011
• Symptomatology and markers of anxiety disorders in Parkinson's disease: a cross-sectional study  
  Leentjens AFG, Dujardin K, Marsh L, Richard IH, Starkstein SE, Martinez-Martin P, Movement Disorders, 1/1/2011
• Anxiety rating scales in Parkinson's disease: a validation study of the Hamilton Anxiety Rating Scale, the Beck Anxiety Inventory and the Hospital Anxiety and Depressi...  
  Leentjens AFG, Dujardin K, Marsh L, Richard IH, Starkstein SE, Martinez-Martin P, Movement Disorders, 1/1/2011
• Apathy and anhedonia rating scales in Parkinson's disease: critique and recommendations  
  Leentjens AFG, Dujardin K, Marsh L, Martinez-Martin P, Richard IH, Starkstein SE, Weintraub D, Sampaio C, Poewe W, Rascol O, Stebbins GT, Goetz CG, Movement Disorders, 1/1/2008
• Anxiety rating scales in Parkinson's disease: critique and recommendations  
  Leentjens AFG, Dujardin K, Marsh L, Martinez-Martin P, Richard IH, Starkstein SE, Weintraub D, Sampaio C, Poewe W, Rascol O, Stebbins GT, Goetz CG, Movement Disorders, 1/1/2008
• Clonidine for attention-deficit/hyperactivity disorder: I Efficacy and tolerability outcomes  
  Palumbo DR, Sallee FR, Pelham WE, Bukstein OG, Daviss B, McDermott MP and the CAT Study Team (I. Richard, Safety Monitoring Committee), Journal of the American Academy of Child and Adolescent Psychiatry, 1/1/2008
• Clonidine for attention-deficit/hyperactivity disorder: II ECG changes and adverse events analysis  
  Daviss WB, Patel NC, Robb AS, McDermott MP, Burkstein OG, Pelham WE, Palumbo D, Harris P, Sallee FR and the CAT Study Team (I. Richard, Safety Monitoring Committee), Journal of the American Academy of Child and Adolescent Psychiatry, 1/1/2008
• The patient's perspective: Results of a survey assessing knowledge about and attitudes toward depression in PD  
  Richard IH, LaDonna K, Hartman R, Podgorski C, Kurlan R and the SAD-PD Study Group, Neuropsychiatric Disease and Treatment, 1/1/2007
• Levodopa responsiveness in disorders with parkinsonism: A review of the literature  
  Constantinescu R, Richard I, Kurlan R, Movement Disorders, 1/1/2007
• Risk Factors for the Development of Somnolence, Edema and Hallucinations in Early Parkinson's Disease  
  Biglan KM, Holloway RG, McDermott MP, Richard IH and the Parkinson Study Group, Neurology, 1/1/2007
• Quetiapine for agitation or psychosis in patients with dementia and parkinsonism  
  Kurlan RM, Cummings JL, Raman R, Thal LJ for the Alzheimer's Disease Cooperative Study Group, Neurology, 1/1/2007
• Medication tolerance and augmentation in restless legs syndrome: The need for drug class rotation  
  Kurlan R, Richard I, Deeley C, Journal of General Internal Medicine, 1/1/2006
• The under-recognition of depression in Parkinson's disease  
  Richard IH, Kurlan R, Neuropsychiatric Disease and Treatment, 1/1/2006
• Join now to see all

Books/Book Chapters

• Parkinson's Disease: Nonmotor and Nondopaminergic Features 
  Chapter: Depression in PD. 
  Page 183 - 192Voss T and Richard IHEditors: Olanow CW, Stocchi F and Lang A.Wiley Blackwell, West Sussex, England2011
• Movement Disorders: 100 Instructive Cases 
  Chapter: Is it PD or DLB? 
  Page 257 - 259Richard IH and Kurlan REditors: Reich SG.Informa Healthdare, London, England2008
• Parkinson's Disease: Diagnosis and Clinical Management 
  Chapter: Anxiety and Panic. 
  Page 179 - 188Richard IH and Kurlan REditors: Factor SA and Weiner WJ.Demos, NYEdition 2nd,2008
• Secondary Dementias 
  Chapter: Cognitive impairment in depression. 
  Richard IHEditors: Kurlan R.Marcel Dekker, NY2006
• Psychiatric Issues in Parkinson's Disease: A Practical Guide 
  Chapter: Management of Advanced Stage Disease. 
  Richard IHEditors: Menza M, Marsh L.Taylor & Francis, London2006
• Current Clinical Neurology: Psychiatry for Neurologists 
  Chapter: An Overview of Depression. 
  Page 33 - 41Richard IH and Lyness JMEditors: Jeste DV and Friedman JH.Humana Press, Boston2005
• Drug Induced Movement Disorders 
  Chapter: Spontaneous movement disorders in psychiatric patients. 
  Richard I, O'Brien C, Kurlan REditors: Factor SA, Lang AE, Weiner WJ.Blackwell Publishers, Malden, MAEdition 2nd,2005
• Neurobase 
  Chapter: Dementia of Huntington's disease. 
  Richard IH, Shoulson IEditors: Gilman S, Golstein GW, Waxman SG.Arbor Publishing, San Diego, CAEdition 4th,1996
• Join now to see all

Abstracts/Posters

• A randomized controlled trial of telemedicine for Parkinson's disease (Connect.Parkinson) in the United States: Interim assessment of investigator and participant expe...
  Achey, M.A., Beck, C.A., Beran, D.B., Boyd, C.M., Schmidt, P.N., Willis, A.W., Riggare, S.S., Simone, R.B., Biglan, K.M., Dorsey, E.R., Aldred, J., Ayan, J., Bull, M.T..., Movement Disorders, 1/1/2015
• Preliminary results for a national case study of virtual care visits for Parkinson's disease.
  Korn, R.E., Achey, M.A., Rodriguez, R., Rizer, K., Richard, I., Dorsey, E.R., Keenan, H.T., Movement Disorders, 1/1/2015
• Predictors of response to antidepressant treatment in depressed patients with Parkinson's disease.
  Leentjens AFG. Wijers A, Moonen AJH, McDonald WM, Richard IH, J Psychosomatic Research; Conference of the European Association of Psychosomatic Medicine (EAPM) Meeting, Sibiu, Romania, 1/1/2014
• Study of duloxetine for depression in Parkinson's disease.
  Lucasson E and Richard IH, 8th International Congress on Mental Dysfunction & Other Non-Motor Features in Parkinson's Disease and Related Disorders, Berlin, Germany, 1/1/2012
• Development of an item bank for the assessment of anxiety in Parkinson's disease.
  M.J. Forjaz, A. Ayala1, A.F.G. Leentjens, K. Dujardin, L. Marsh, I.H. Richard, S.E. Starkstein, P. Martinez-Martin, 7th International Congress on Mental Dysfunctions and Other Non-Motor Features in Parkinson's Disease and Related Disorders, Barcelona, Spain, 1/1/2010
• A multicenter randomized, double-blind, placebo-controlled trial of paroxetine and venlafaxine extended release for depression in Parkinson's disease.
  Richard IH, McDermott M, McDonald WM on behalf of the SAD-PD Study Group, Movement Disorders; "Hot Topic" at the World Parkinson Congress, Glasgow, Scotland, UK, September 2010, 1/1/2010
• Mood fluctuations during continuous levodopa infusion in six patients with Parkinson's disease.
  Frank S, Richard IH, LaDonna K, McDermott M, Justus A, Kurlan R, 15th Annual Meeting of the American Neuropsychiatric Association (ANPA), Bal Harbor, FL, 1/1/2004
• Communicating for the public good: Breaking myths about depression and Parkinson's disease.
  LaDonna K, Hartman RL, Richard IH, Podgorsky C, Eastern Communications Association Conference, Washington, DC, 1/1/2003
• Evaluation of the long-duration benefit from levodopa: Results from the ELLDOPA (Earlier vs. later LevoDOPA) Study.
  Fahn S, Parkinson Study Group (Site Investigator), Movement Disorders, 1/1/2003
• Does levodopa slow or hasten the rate of progression of Parkinson disease? The results of the ELLDOPA trial.
  Parkinson Study Group (Site Investigator), Neurology, 1/1/2003
• Beta-CIT scans without evidence of dopaminergic deficit (SWEDD) in the ELLDOPA-CIT and CALM-CIT study: Long-term imaging.
  Marek KL, Seibyl J, Parkinson Study Group (Site Investigator), Neurology, 1/1/2003
• Depressive symptoms in Parkinson's disease are underrecognized.
  Richard IH, Justus AW, Caine E, Kurlan R, Journal of Neuropsychiatry and Clinical Neurosciences, 1/1/2002
• Results of the ELLDOPA (earlier vs. later levodopa) study.
  Parkinson Study Group (Site Investigator), Movement Disorders, 1/1/2002
• Rivastigmine-induced worsening of motor function and mood in a patient with Parkinson's disease.
  Richard, IH; Justus, AW; Greig, N; Marshall, F and Kurlan, R, Movement Disorders, 1/1/2001
• Low dose clozapine for the treatment of drug-induced psychosis in idiopathic Parkinson's disease: Results of the double-blind, placebo controlled PSYCLOPS trial.
  Friedman JH, Comella C, Factor S, Kurlan R, Parsa M, Pfeiffer R, Richard I and the Parkinson Study Group, Neurology, 1/1/1998
• Join now to see all

Lectures

• "To Your Health" Community Lecture Series" 
  Pittsford, NY - 1/1/2013
• "Challenges and Hopes for Parkinson's disease" 
  Canandaigua, NY - 1/1/2012
• "Updates on Research in PD" 
  Rochester, NY - 1/1/2011
• Update on Parkinson's Disease. 
  Rochester, NY - 1/1/2010
• "Essential Tremor: Diagnosis, New Concepts and Medical Treatment" 
  Summit, NJ - 1/1/2010
• "Approaches to treatment of early and later Parkinson's disease" 
  Mario's Restaurant, Rochester, NY - 1/1/2010
• "Deep Brain Stimulation for PD" 
  Rochester, NY - 1/1/2008
• Invited Speaker: "Deep Brain Stimulation for PD" 
  Rochester, NY - 1/1/2008
• "A New Look at Depression and its Treatment: What We've Learned from Parkinson's disease" 
  1/1/2008
• "Learning about Essential Tremor: Diagnosis and Treatment Options" 
  Sacket's Harbor, NY - 1/1/2008
• "Parkinson's Disease: Clinical Features and Indications for Surgery" 
  Rochester, NY - 1/1/2008
• "Hot Topics: Cognitive Impairment in PD" 
  New York Academy of Sciences, New York, NY - 1/1/2007
• "Non-Motor Aspects of PD" 
  1/1/2007
• "Behind the Mask:   A Closer Look at Depression in Parkinson's Disease" 
  1/1/2006
• "Comorbidities in Parkinson's Disease" 
  Washington, DC - 1/1/2006
• "Approaches to the recognition and management of psychiatric symptoms in movement disorders" 
  Miami, FL - 1/1/2005
• "Behind the Mask: Looking at Depression in Parkinson's Disease" 
  1/1/2004
• "Issues Surrounding the Diagnosis and Treatment of Depression in Parkinson's Disease" 
  Denver - 1/1/2002
• "Medications in Parkinson's Disease-Where to Start" 
  1/1/2001
• "Parkinson's Disease: How to Interpret all of the New Clinical Research Findings" 
  Philadelphia - 1/1/2001
• "Treating the Behavioral Features of Parkinson's Disease" 
  1/1/1999
• "Current Approaches to the Treatment of Parkinson's Disease" 
  1/1/1999
• "Update on the Treatment of Parkinson's Disease" 
  1/1/1999
• "Life Threatening Drug-Induced Neurological Syndromes" 
  1/1/1998
• "Issues Surrounding the Use of Psychotropic Medications in Parkinson's Disease" 
  1/1/1998
• Join now to see all

Other

• "Sleep Disorders in PD" (MJFF Webinar) 
  Irene Hegeman Richard, MD, MJFF website
  1/14/2014
• "The link between depression and Parkinson's disease" 
  Irene Hegeman Richard, MD
  http://www.reuters.com/article/2014/08/15/us-people-robinwilliams-idUSKBN0GE1YQ20140815
  1/1/2014
• "Premotor symptoms of Parkinson's disease" 
  Irene Hegeman Richard, MD
  http://www.usatoday.com/story/news/nation/2013/09/24/parkinsons-disease-fox/2862179/[usatoday.com][usatoday.com]
  1/1/2013
• "New Research on Treating Depression in Parkinson's Patients." 
  Irene Hegeman Richard, MD, MJFF website
  1/1/2012
• "Antidepressant medications treat depression and do not worsen symptoms of PD" 
  Irene Hegeman Richard, MD
  http://www.medscape.com/viewarticle/761878
  1/1/2012
• "News in Context: Gene Therapy Trial Reports Improvements in PD Symptoms." 
  Irene Hegeman Richard, MD, Lancet Neurology, Volume 16
  1/1/2011
• "Importance of progression markers in Parkinson's disease" 
  Irene Hegeman Richard, MD
  http://www.clipsyndicate.com/video/playlist/12542/2925630?title=parkinsons
  1/1/2011
• "The Impact of Depression on PD" (Podcast Interview with David Iverson) 
  Irene Hegeman Richard, MD, MJFF website
  1/1/2010
• "The emotional toll of Parkinson's disease" 
  Irene Hegeman Richard, MD, Expert Q&A New York Times with Marilynn Larkin
  http://www.nytimes.com/ref/health/healthguide/esn-parkinsons-expert.html
  1/1/2008
• "News in Context: PD Drug Pergolide Pulled from U.S. Market: Implications for Patients and Their Families" 
  Irene Hegeman Richard, MD
  1/1/2007
• Acute, drug-induced, life-threatening neurological syndromes. 
  Richard, IH, The Neurologist
  1/1/1998
• Join now to see all